Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Accumulated Expenses (2016 - 2025)

Utah Medical Products has reported Accumulated Expenses over the past 16 years, most recently at $853000.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $853000.0 for Q4 2025, down 72.13% from a year ago — trailing twelve months through Dec 2025 was $853000.0 (down 72.13% YoY), and the annual figure for FY2025 was $853000.0, down 72.13%.
  • Accumulated Expenses for Q4 2025 was $853000.0 at Utah Medical Products, down from $2.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for UTMD hit a ceiling of $5.0 million in Q1 2023 and a floor of $853000.0 in Q4 2025.
  • Median Accumulated Expenses over the past 5 years was $3.6 million (2022), compared with a mean of $3.4 million.
  • Biggest five-year swings in Accumulated Expenses: soared 287.1% in 2022 and later crashed 72.13% in 2025.
  • Utah Medical Products' Accumulated Expenses stood at $1.2 million in 2021, then soared by 287.1% to $4.7 million in 2022, then fell by 16.89% to $3.9 million in 2023, then decreased by 22.33% to $3.1 million in 2024, then crashed by 72.13% to $853000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $853000.0 (Q4 2025), $2.2 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.